ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,281Medicare Part D Prescriptions Filled, Including Refills

Rank: 63 out of 917

$535K Total Retail Price of All Prescriptions

Rank: 99 out of 917

374 Patients Receiving at Least One Drug in Part D
98%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Washington
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 374 patients filled at least one prescription for a schedule two drug, compared to an average of 7%.

Schedule Three
Controlled Substances

13% of this provider’s 374 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

3% of this provider’s 11,086 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

29% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$47 was the average price of a prescription from this provider, compared to $56 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Washington
AMLODIPINE BESYLATE 580 570 1 5
LISINOPRIL 379 377 2 1
SIMVASTATIN 359 340 3 2
FUROSEMIDE 347 347 4 7
LEVOTHYROXINE SODIUM 300 264 5 3
RANITIDINE HCL 283 283 6 29
ATENOLOL 278 278 7 12
METOPROLOL TARTRATE 253 241 8 11
METFORMIN HCL 220 220 9 8
MIRTAZAPINE 198 198 10 39
DONEPEZIL HCL 195 195 11 32
SERTRALINE HCL 189 177 12 24
HYDROCODONE-ACETAMINOPHEN 179 169 S3 13 6
GLYBURIDE 174 174 R 14 71
POTASSIUM CHLORIDE 170 169 15 16
OMEPRAZOLE 164 164 16 4
ALLOPURINOL 161 161 17 31
ALENDRONATE SODIUM 160 160 18 23
WARFARIN SODIUM 158 151 19 10
LANTUS 153 145 20 37
ATORVASTATIN CALCIUM 149 149 21 14
TAMSULOSIN HCL 145 145 22 25
NAMENDA 131 131 23 43
METOPROLOL SUCCINATE 130 130 24 18
TERAZOSIN HCL 124 124 25 108
TRAZODONE HCL 117 114 26 22
CITALOPRAM HBR 115 115 27 15
QUETIAPINE FUMARATE 110 110 28 52
FAMOTIDINE 108 108 29 91
ZOLPIDEM TARTRATE 103 103 30 21
CARVEDILOL 100 100 31 33
LOVASTATIN 100 100 31 19
RISPERIDONE 99 93 33 51
DIOVAN 91 91 34 49
CLOPIDOGREL 88 88 35 50
LIDODERM 83 83 36 64
ACTOS 79 79 37 112
HYDROCHLOROTHIAZIDE 76 76 38 9
DOXAZOSIN MESYLATE 76 76 38 74
NOVOLIN N 74 74 40 125
BACLOFEN 74 74 40 82
GLIPIZIDE 70 70 42 40
CARBIDOPA-LEVODOPA 67 67 43 86
LEVETIRACETAM 66 47 44 120
ACETAMINOPHEN-CODEINE 62 62 S3 45 109
LOSARTAN POTASSIUM 60 60 46 13
FINASTERIDE 59 59 47 77
PANTOPRAZOLE SODIUM 56 56 48 44
NOVOLIN 70-30 55 55 49 236
LIDOCAINE HCL 54 54 50 246
EXELON 54 54 50 207
CRESTOR 54 54 50 30
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on June 22, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.